Literature DB >> 10372471

Preliminary tests of a cognitive model of generalized anxiety disorder.

A Wells1, K Carter.   

Abstract

Although worry is the central feature of Generalised Anxiety Disorder (GAD), little is known about the factors that contribute to pathological or problematic worry. In a recent cognitive model of GAD, Wells, A. (1995) proposed that negative appraisal of worrying itself (meta-worry or type 2 worry) should be distinguished from other types of worrying (type 1 worry). A central feature of this model is the idea that individuals with GAD hold rigid positive beliefs about the usefulness of worrying as a coping strategy. However, these individuals also hold negative beliefs and appraise worrying as uncontrollable and dangerous. This combination of cognitions and associated responses leads to an increased frequency and generality of worrying, and thus to the pathological worry characteristic of GAD. This paper reports a preliminary test of the hypothesis that meta-worry contributes to problematic and pathological worrying, and this relationship is independent of the frequency of other types of worry. In testing for associations between worry dimensions we controlled for overlaps with Trait anxiety, and the controllability of worrying. Results of a series of regression analyses support the hypothesis that pathological worry is associated with meta-worry and this association is independent of Trait-anxiety and type 1 worry. The clinical implications of these data are briefly discussed.

Entities:  

Mesh:

Year:  1999        PMID: 10372471     DOI: 10.1016/s0005-7967(98)00156-9

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  16 in total

1.  Changes over 6-months in health-related quality of life in a matched sample of Hispanics and non-Hispanics with heart failure.

Authors:  Barbara Riegel; Beverly Carlson; Dale Glaser; Tomas Romero
Journal:  Qual Life Res       Date:  2003-09       Impact factor: 4.147

Review 2.  The developmental psychopathology of worry.

Authors:  Sarah J Kertz; Janet Woodruff-Borden
Journal:  Clin Child Fam Psychol Rev       Date:  2011-06

Review 3.  The metacognitive model of generalized anxiety disorder in children and adolescents.

Authors:  Danielle M Ellis; Jennifer L Hudson
Journal:  Clin Child Fam Psychol Rev       Date:  2010-06

4.  Specificity of social anxiety disorder as a risk factor for alcohol and cannabis dependence.

Authors:  Julia D Buckner; Norman B Schmidt; Alan R Lang; Jason W Small; Robert C Schlauch; Peter M Lewinsohn
Journal:  J Psychiatr Res       Date:  2007-02-23       Impact factor: 4.791

5.  Changes in proposed mechanisms of action during an acceptance-based behavior therapy for generalized anxiety disorder.

Authors:  Sarah A Hayes; Susan M Orsillo; Lizabeth Roemer
Journal:  Behav Res Ther       Date:  2009-11-18

6.  Efficacy of an acceptance-based behavior therapy for generalized anxiety disorder: evaluation in a randomized controlled trial.

Authors:  Lizabeth Roemer; Susan M Orsillo; Kristalyn Salters-Pedneault
Journal:  J Consult Clin Psychol       Date:  2008-12

7.  Sleep disturbance and depressive symptoms in adolescence: the role of catastrophic worry.

Authors:  Nanette S Danielsson; Allison G Harvey; Shane Macdonald; Markus Jansson-Fröjmark; Steven J Linton
Journal:  J Youth Adolesc       Date:  2012-09-12

Review 8.  A contemporary view of applied relaxation for generalized anxiety disorder.

Authors:  Sarah A Hayes-Skelton; Lizabeth Roemer; Susan M Orsillo; Thomas D Borkovec
Journal:  Cogn Behav Ther       Date:  2013-06-04

9.  An Acceptance-Based Behavioral Therapy for Individuals with Generalized Anxiety Disorder.

Authors:  Sarah A Hayes-Skelton; Susan M Orsillo; Lizabeth Roemer
Journal:  Cogn Behav Pract       Date:  2011-04-17

10.  A randomized clinical trial comparing an acceptance-based behavior therapy to applied relaxation for generalized anxiety disorder.

Authors:  Sarah A Hayes-Skelton; Lizabeth Roemer; Susan M Orsillo
Journal:  J Consult Clin Psychol       Date:  2013-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.